印度药物监管机构和印度临床试验注册局的数据并不总是匹配
Iqbal S Bhalla1, Adithi Gopadi Ravindranath2, Ravi Vaswani3
1School of Geography and the Environment, Oxford University, Oxford, United Kingdom.
Frontiers in medicine
|March 4, 2024
概括
印度的监管试验显示,药物监管机构的许可和印度临床试验注册局 (CTRI) 关于试验场所和调查人员的记录之间存在重大差异. 提高数据准确性和透明度对于可靠的临床研究至关重要.
科学领域:
- 临床试验法规 临床试验法规
- 药物监督 药物监督 药物监督
- 公共卫生政策 公共卫生政策
背景情况:
- 印度的监管试验需要药物监管机构的许可和自2019年3月19日以来在印度临床试验注册局 (CTRI) 的强制性注册.
- 确保监管批准和注册数据之间的一致性对于试验完整性至关重要.
研究的目的:
- 为了确定药物监管机构批准的试验的匹配CTRI记录.
- 为了比较监管许可信中列出的试验场所和主要研究人员的准确性,与CTRI记录相比.
主要方法:
- 开发了一种方法来比较监管许可信与CTRI记录.
- 通过比较标题,药物干预和指示,手动验证了151个"真实对".
- 系统地检查了试验场所和主要调查人员的差异.
主要成果:
- 在许可信和CTRI记录之间,在试验地点和主要研究人员的数量和身份方面发现了实质性的差异.
- 这些不一致性凸显了数据准确性和透明度方面的潜在问题.
结论:
- 监管文件和CTRI记录之间的差异引发了对印度监管试验的准确性和透明度的担忧.
- 建议包括改进数据提取,交叉引用,公开披露变化,加强机构道德委员会监督以提高透明度.
相关概念视频
Drug Regulation
1.4K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.4K
Clinical Trials
6.7K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.7K
Pharmacovigilance
833
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
833
Clinical Trials: Overview
2.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.9K
Drug Control Governance: Regulatory Bodies and Their Impact
158
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
158
Drug Dosage Regimen: Overview
3.5K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.5K


